Skip to content
Vaxxinova continuously adapts the range of solutions according to the market needs. The shown pathogens (LINK to pdf ) can be used in combinations and with different adjuvants.

Pathogen Spectrum

Vaxxinova continuously adapts the range of solutions according to the market needs. The shown pathogens (LINK to pdf ) can be used in combinations and with different adjuvants.

Vaccines

Autogenous vaccines (farm-specific vaccines) are individually manufactured products based on state-of-the-art diagnostics. Vaxxinova Autogenous Vaccines GmbH provides herd-specific prevention solutions for veterinarians if registered vaccines are not available and no longer effective.

At Vaxxinova, an experienced team of veterinarians is responsible for the strain selection for the individual flock. It is important to monitor the disease situation regularly and continuously in the herd, in order to record possible changes in the pathogen spectrum and as a consequence to update the autogenous vaccine. This ensures a lasting protection.

Our autogenous vaccines are marketed under the brand name Govaxx®.

Poultry DE
Swine DE

Pathogens

Vaxxinova Autogenous Vaccines GmbH offers bacterial and viral autogenous vaccines for production animals based on state-of-the-art manufacturing methods. We provide both mono- and combination vaccines. Vaxxinova has many years of experience in the research, development, manufacture and application of autogenous vaccines.

In addition to the antigen, also the adjuvant has a decisive influence on the success of the vaccination. Vaxxinova uses a highly compatible and highly potent oil-based adjuvant. The autogenous vaccine is thus formulated as a water-in-oil emulsion. Formulations with aluminum hydroxide are also available.

Product Quality

Our Production and Quality Control teams are dedicated to producing and testing herd-specific vaccines according to high quality standard procedures.

Vaxxinova Autogenous Vaccines GmbH develops and produces autogenous vaccines for poultry, swine and cattle in these production facilities. These are produced with inactivated antigens and mostly composed of high quality adjuvants. These formulations have resulted in safe and good quality vaccines.

Production DE

Vaxxinova Autogenous Vaccines GmbH strictly follows the German legislation for autogenous vaccines as published in the “question and answer paper” of the Central Authority of the states for Health Protection with regard to Medicinal Products and Medical Devices (ZLG). Authorities from Lower-Saxony and the VMD from the United Kingdom regularly inspect our compliance. These authorities have given Vaxxinova the Manufacturing Authorization to produce our autogenous vaccines.

 

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.